UHS

Universal Health Services, Inc. Healthcare - Medical Care Facilities Investor Relations →

NO
12.0% ABOVE
↓ Approaching Was 13.0% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $173.28
14-Week RSI 64
Rel. Volume (14w) This week's trading vs. the 14-week average 0.9x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.06

Universal Health Services, Inc. (UHS) closed at $194.07 as of 2026-11-13, trading 12.0% above its 200-week moving average of $173.28. The stock is currently moving closer to the line, down from 13.0% last week. The 14-week RSI sits at 64, indicating neutral momentum.

Trading volume is running at 0.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.06 ratio) is neutral — neither side is clearly dominating.

Over the past 2318 weeks of data, UHS has crossed below its 200-week moving average 40 times. On average, these episodes lasted 13 weeks. Historically, investors who bought UHS at the start of these episodes saw an average one-year return of +28.4%.

With a market cap of $11.2 billion, UHS is a large-cap stock. The company generates a free cash flow yield of 6.7%, which is healthy. Return on equity stands at 19.7%, a solid level. The stock trades at 1.5x book value.

The company has been aggressively buying back shares, reducing its share count by 13.5% over the past three years.

Over the past 33.9 years, a hypothetical investment of $100 in UHS would have grown to $11543, compared to $3136 for the S&P 500. That represents an annualized return of 15.0% vs 10.7% for the index — confirming UHS as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been growing at a 46.5% compound annual rate, with 4 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: UHS vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After UHS Crosses Below the Line?

Across 29 historical episodes, buying UHS when it crossed below its 200-week moving average produced an average return of +23.4% after 12 months (median +15.0%), compared to +8.8% for the S&P 500 over the same periods. 85% of those episodes were profitable after one year. After 24 months, the average return was +32.5% vs +20.9% for the index.

Each line shows $100 invested at the moment UHS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices UHS would reach each dislocation threshold.

Current Bean Score -1.04σ
Current FCF Yield 11.18%
Baseline Yield 12.35%
Historical σ 0.51pp

Dislocation Price Levels

Prices where UHS's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-09-30).

LevelσPriceSignal
Deep Value+2σ$170.46Unusually cheap — analysis point
Value+1σ$177.55Cheap vs. own history
Fair Value+0σ$185.27Historical mean behavior
Expensive-1σ$193.68Expensive vs. own history
Deep Expensive-2σ$202.90Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-10-27$5.15$5.22+1.3%
2026-07-27$6.01$5.98-0.5%
2026-04-27$5.46$5.62+3.0%
2026-02-25$5.91$5.88-0.5%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from UHS's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

⚠ Earnings quality deteriorating — net income is outrunning free cash flow vs this company's own norm. Cheapness signals here deserve extra scrutiny.
Yield Dislocation -0.21σ Dividend yield vs own 10-yr norm
Drawdown Score +0.36σ Distance from line vs own history
Sector-Relative +0.42σ Vs sector median this week
Buyback Acceleration -1.3pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History -0.4pp Vs own recent annual mean
Earnings Quality Deteriorating Accrual gap trend (+3.1pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

UHS has crossed below its 200-week MA 40 times with an average 1-year return of +28.4% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jun 1982Aug 198299.5%+210.7%+18864.0%
Oct 1983Jul 19844334.6%-10.9%+12830.0%
Sep 1984Jan 19851927.5%+18.6%+13844.1%
Sep 1985Jun 19863816.3%+13.8%+12161.2%
Jul 1986Aug 198621.2%-41.8%+11558.2%
Oct 1986Jun 198913972.5%-57.0%+16438.4%
Oct 1989Nov 1989515.6%-18.8%+20142.5%
Dec 1989Dec 198921.6%+4.3%+19853.3%
Apr 1990May 199068.1%+70.1%+20746.7%
Aug 1990Aug 199016.5%+110.3%+23981.6%
Sep 1990Dec 19901117.0%+120.3%+23573.4%
Aug 1999Jan 20002139.7%+84.4%+2275.4%
Feb 2000Mar 200032.9%+107.3%+2110.0%
Feb 2003Feb 200315.4%+60.7%+1147.4%
Mar 2003Mar 200310.0%+21.8%+1072.4%
Apr 2004Nov 2004308.6%+22.6%+893.8%
Dec 2004Feb 200586.0%+5.7%+872.7%
Oct 2005Oct 200510.8%+27.6%+832.9%
Oct 2005Nov 200521.5%+19.0%+837.6%
Dec 2005Jan 200642.1%+19.3%+820.2%
Jul 2007Aug 200723.4%+25.5%+769.1%
Oct 2007Nov 200774.7%-17.5%+750.2%
Dec 2007Feb 200887.8%-23.2%+750.6%
Sep 2008May 20093339.0%+18.0%+722.2%
Jun 2009Jul 200945.5%+66.2%+742.1%
Jul 2017Jan 20182414.6%+12.5%+81.3%
Feb 2018Feb 201810.5%+14.4%+75.0%
Apr 2018Apr 201812.7%+13.4%+76.3%
May 2018Jul 2018105.6%+3.7%+71.1%
Oct 2018Oct 201813.3%+19.7%+74.1%
Dec 2018Jan 201934.8%+26.6%+75.6%
May 2019Jun 201910.8%-11.4%+68.0%
Feb 2020Nov 20203738.9%+1.3%+61.6%
Oct 2021Nov 202112.6%-5.1%+60.5%
Nov 2021Dec 202134.6%+4.5%+60.6%
Apr 2022Nov 20222930.8%+23.5%+62.0%
Feb 2023Apr 202357.7%+35.4%+55.2%
Sep 2023Oct 202372.7%+85.2%+55.9%
May 2026Aug 20261315.7%N/A+23.3%
Aug 2026Sep 202610.7%N/A+14.4%
Average13—+28.4%—

Frequently Asked Questions

Is UHS below its 200-week moving average?

No. Universal Health Services, Inc. (UHS) is currently 12.0% above its 200-week moving average of $173.28. It would need to fall to $173.28 to cross below the line.

What is UHS's 200-week moving average price?

Universal Health Services, Inc.'s 200-week moving average is $173.28 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when UHS drops below its 200-week moving average?

UHS has crossed below its 200-week moving average 40 times in our data. On average, buying at that moment produced a one-year return of +28.4%. These dips have historically been decent entry points. These episodes lasted 13 weeks on average.

Is UHS a good value right now?

Here's what our data says about UHS as of 2026-11-13: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 64. Free cash flow yield is 6.7%. Return on equity is 19.7%. Price-to-book is 1.5x. This is not a buy or sell recommendation — always do your own research.

How does UHS compare to the S&P 500?

Over the past 33.9 years, $100 invested in UHS would have grown to $11543, compared to $3136 for the S&P 500. That's 15.0% annualized vs 10.7% for the index. UHS has outperformed the broader market over this period.

Does UHS pay a dividend?

Yes. Universal Health Services, Inc. currently pays a dividend yield of 41.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13